Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
RXRxSight, Inc. logo

RxSight, Inc. (RXST)

NASDAQ Global Market · Currency in USD
$5.02 ▼ -0.06 (-1.18%)
At close: Oct 23, 4:00 PM ET. Market closed.
$5.02 ▲ +0.00 (+0.00%)
After hours: Oct 23, 7:30 PM ET

Summary

Previous Close
$5.08
Open
$5.07
Day's Range
$5.01 – $5.11
52 Week Range
$4.40 – $13.22
Volume
326,804
Avg. Volume
985,241
Market Cap
$208.80M
Beta (5Y Monthly)
1.14
PE Ratio (TTM)
--
EPS (TTM)
-$1.13
Earnings Date
Nov 3, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$7.31

Profile: RxSight, Inc.

Sector
Healthcare
Industry
Medical - Devices
Full-time employees
461
CEO
Aziz Mottiwala

As a medical technology enterprise, RxSight, Inc. (which operated as Calhoun Vision, Inc. until its rebranding in February 2017) specializes in the innovation, manufacturing, and distribution of light-adjustable intraocular lenses (LALs). These advanced lenses are specifically designed for use in cataract surgery, serving patients in both domestic and international markets. The cornerstone of the company's offerings is the RxSight system, a sophisticated solution that enables ophthalmologists to precisely tailor and enhance a patient's visual acuity following cataract removal.

Earnings

Next report: Tue, Nov 3, 2026
EPS estimate -$0.29 · Revenue est. $27.19M
DateEst.Actual
Aug 5, 2026-$0.33-$0.29Beat
May 6, 2026-$0.30-$0.38Miss
Feb 25, 2026-$0.33-$0.22Beat
Nov 5, 2025-$0.34-$0.24Beat
Aug 7, 2025-$0.25-$0.29Miss
May 7, 2025-$0.22-$0.20Beat

Analyst view

Consensus price target
$7.31 ▲ +45.6%
Range $5.50 – $11.00
Rating: Hold
Buy 25% · Hold 58% · Sell 17%

Get free alerts on RXST and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.